MAPT and Alzheimer disease: Because tau and β-amyloid are the main neurodegeneration hallmarks in AD and develop progressively in humans and in the 3xTg-AD mouse model, we analyzed the preventive effect of quercetin in the apparition of these markers after 1 year of oral administration.